Refractory Extranodal Marginal Zone Lymphoma
1 clinical trials · Condition
◉ Watch Refractory Extranodal Marginal Zone Lymphoma
| Record | Firm | Date |
|---|---|---|
| Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma (NCT03147885) | Barbara Ann Karmanos Cancer Institute | 2017-06-20 |
Track Refractory Extranodal Marginal Zone Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.